NCT01326026 - Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

222

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec

Injected subcutaneously (under the skin) once daily. Dose individually adjusted.

DRUG

insulin degludec

Injected subcutaneously (under the skin) once daily. Dose individually adjusted in a stepwise manner.

Trial Locations (45)

10301

Novo Nordisk Investigational Site, Staten Island

12163

Novo Nordisk Investigational Site, Berlin

19027

Novo Nordisk Investigational Site, Melrose Park

20520

Novo Nordisk Investigational Site, Turku

27408

Novo Nordisk Investigational Site, Greensboro

28223

Novo Nordisk Investigational Site, Pozuelo de Alarcón

29006

Novo Nordisk Investigational Site, Málaga

29200

Novo Nordisk Investigational Site, Antequera

31909

Novo Nordisk Investigational Site, Columbus

33206

Novo Nordisk Investigational Site, Gijón

33210

Novo Nordisk Investigational Site, Tampere

33603

Novo Nordisk Investigational Site, Tampa

34741

Novo Nordisk Investigational Site, Kissimmee

35216

Novo Nordisk Investigational Site, Birmingham

35801

Novo Nordisk Investigational Site, Huntsville

38343

Novo Nordisk Investigational Site, Humboldt

45005

Novo Nordisk Investigational Site, Franklin

47714

Novo Nordisk Investigational Site, Evansville

48145

Novo Nordisk Investigational Site, Münster

56564

Novo Nordisk Investigational Site, Neuwied

59102

Novo Nordisk Investigational Site, Billings

62711

Novo Nordisk Investigational Site, Springfield

66299

Novo Nordisk Investigational Site, Friedrichsthal

66333

Novo Nordisk Investigational Site, Völklingen

77095

Novo Nordisk Investigational Site, Houston

78224

Novo Nordisk Investigational Site, San Antonio

80401

Novo Nordisk Investigational Site, Golden

84403

Novo Nordisk Investigational Site, Ogden

84790

Novo Nordisk Investigational Site, St. George

91345

Novo Nordisk Investigational Site, Mission Hills

91606

Novo Nordisk Investigational Site, North Hollywood

91950

Novo Nordisk Investigational Site, National City

92037

Novo Nordisk Investigational Site, La Jolla

92111

Novo Nordisk Investigational Site, San Diego

92801

Novo Nordisk Investigational Site, Anaheim

70461-4231

Novo Nordisk Investigational Site, Slidell

02914

Novo Nordisk Investigational Site, East Providence

76543-5600

Novo Nordisk Investigational Site, Killeen

00260

Novo Nordisk Investigational Site, Helsinki

FI-04200

Novo Nordisk Investigational Site, Kerava

FI-20100

Novo Nordisk Investigational Site, Turku

06679

Novo Nordisk Investigational Site, Hohenmölsen

04001

Novo Nordisk Investigational Site, Almería

07014

Novo Nordisk Investigational Site, Palma de Mallorca

07198

Novo Nordisk Investigational Site, Palma de Mallorca